{"count":3,"next":null,"previous":null,"results":[{"url":"https://lda.gov/api/v1/filings/d2c2c0b6-6019-4629-b481-eece9c1d1329/","filing_uuid":"d2c2c0b6-6019-4629-b481-eece9c1d1329","filing_type":"RR","filing_type_display":"Registration","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/d2c2c0b6-6019-4629-b481-eece9c1d1329/print/","filing_document_content_type":"text/html","income":null,"expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Nora M. Wong","dt_posted":"2026-09-04T11:46:45-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"325 Hudson St","registrant_address_2":"4th floor","registrant_different_address":null,"registrant_city":"New York","registrant_state":"NY","registrant_zip":"10013","registrant":{"id":401111004,"url":"https://lda.gov/api/v1/registrants/401111004/","house_registrant_id":null,"name":"CUREPSP","description":null,"address_1":"325 Hudson Street","address_2":"4th Floor","address_3":null,"address_4":null,"city":"New York","state":"NY","state_display":"New York","zip":"10013","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"NORA WONG","contact_telephone":"+1 551-306-5982","dt_updated":"2026-09-04T11:34:50.236473-04:00"},"client":{"id":74863,"url":"https://lda.gov/api/v1/clients/74863/","client_id":74863,"name":"CUREPSP","general_description":"Non profit health organization","client_government_entity":null,"client_self_select":true,"state":"NY","state_display":"New York","country":"US","country_display":"United States of America","ppb_state":"NY","ppb_state_display":"New York","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2026-07-17"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Federal funding for biomedical and neurological disease research, including NIH and related federal research programs; FY 2027 appropriations affecting progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), multiple system atrophy (MSA), and related neurodegenerative diseases; (H.R. 7779) HEALTHY BRAINS Act of 2026, including provisions related to neurological disease research and environmental risk factors; congressional resolution recognizing PSP Awareness Month H.Res.1318 and S.Res.752.","foreign_entity_issues":null,"lobbyists":[{"lobbyist":{"id":155101,"prefix":null,"prefix_display":null,"first_name":"NORA","nickname":null,"middle_name":null,"last_name":"WONG","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":155102,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"BALASALLE","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[]},{"general_issue_code":"ENV","general_issue_code_display":"Environment/Superfund","description":"Federal funding for biomedical and neurological disease research, including NIH and related federal research programs; FY 2027 appropriations affecting progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), multiple system atrophy (MSA), and related neurodegenerative diseases; (H.R. 7779) HEALTHY BRAINS Act of 2026, including provisions related to neurological disease research and environmental risk factors; congressional resolution recognizing PSP Awareness Month H.Res.1318 and S.Res.752.","foreign_entity_issues":null,"lobbyists":[{"lobbyist":{"id":155101,"prefix":null,"prefix_display":null,"first_name":"NORA","nickname":null,"middle_name":null,"last_name":"WONG","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":155102,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"BALASALLE","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[]},{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Federal funding for biomedical and neurological disease research, including NIH and related federal research programs; FY 2027 appropriations affecting progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), multiple system atrophy (MSA), and related neurodegenerative diseases; (H.R. 7779) HEALTHY BRAINS Act of 2026, including provisions related to neurological disease research and environmental risk factors; congressional resolution recognizing PSP Awareness Month H.Res.1318 and S.Res.752.","foreign_entity_issues":null,"lobbyists":[{"lobbyist":{"id":155101,"prefix":null,"prefix_display":null,"first_name":"NORA","nickname":null,"middle_name":null,"last_name":"WONG","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":155102,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"BALASALLE","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/d2c2c0b6-6019-4629-b481-eece9c1d1329/","filing_uuid":"d2c2c0b6-6019-4629-b481-eece9c1d1329","filing_type":"RR","filing_type_display":"Registration","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/d2c2c0b6-6019-4629-b481-eece9c1d1329/print/","filing_document_content_type":"text/html","income":null,"expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Nora M. Wong","dt_posted":"2026-09-04T11:46:45-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"325 Hudson St","registrant_address_2":"4th floor","registrant_different_address":null,"registrant_city":"New York","registrant_state":"NY","registrant_zip":"10013","registrant":{"id":401111004,"url":"https://lda.gov/api/v1/registrants/401111004/","house_registrant_id":null,"name":"CUREPSP","description":null,"address_1":"325 Hudson Street","address_2":"4th Floor","address_3":null,"address_4":null,"city":"New York","state":"NY","state_display":"New York","zip":"10013","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"NORA WONG","contact_telephone":"+1 551-306-5982","dt_updated":"2026-09-04T11:34:50.236473-04:00"},"client":{"id":74863,"url":"https://lda.gov/api/v1/clients/74863/","client_id":74863,"name":"CUREPSP","general_description":"Non profit health organization","client_government_entity":null,"client_self_select":true,"state":"NY","state_display":"New York","country":"US","country_display":"United States of America","ppb_state":"NY","ppb_state_display":"New York","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2026-07-17"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Federal funding for biomedical and neurological disease research, including NIH and related federal research programs; FY 2027 appropriations affecting progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), multiple system atrophy (MSA), and related neurodegenerative diseases; (H.R. 7779) HEALTHY BRAINS Act of 2026, including provisions related to neurological disease research and environmental risk factors; congressional resolution recognizing PSP Awareness Month H.Res.1318 and S.Res.752.","foreign_entity_issues":null,"lobbyists":[{"lobbyist":{"id":155101,"prefix":null,"prefix_display":null,"first_name":"NORA","nickname":null,"middle_name":null,"last_name":"WONG","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":155102,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"BALASALLE","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[]},{"general_issue_code":"ENV","general_issue_code_display":"Environment/Superfund","description":"Federal funding for biomedical and neurological disease research, including NIH and related federal research programs; FY 2027 appropriations affecting progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), multiple system atrophy (MSA), and related neurodegenerative diseases; (H.R. 7779) HEALTHY BRAINS Act of 2026, including provisions related to neurological disease research and environmental risk factors; congressional resolution recognizing PSP Awareness Month H.Res.1318 and S.Res.752.","foreign_entity_issues":null,"lobbyists":[{"lobbyist":{"id":155101,"prefix":null,"prefix_display":null,"first_name":"NORA","nickname":null,"middle_name":null,"last_name":"WONG","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":155102,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"BALASALLE","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[]},{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Federal funding for biomedical and neurological disease research, including NIH and related federal research programs; FY 2027 appropriations affecting progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), multiple system atrophy (MSA), and related neurodegenerative diseases; (H.R. 7779) HEALTHY BRAINS Act of 2026, including provisions related to neurological disease research and environmental risk factors; congressional resolution recognizing PSP Awareness Month H.Res.1318 and S.Res.752.","foreign_entity_issues":null,"lobbyists":[{"lobbyist":{"id":155101,"prefix":null,"prefix_display":null,"first_name":"NORA","nickname":null,"middle_name":null,"last_name":"WONG","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":155102,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"BALASALLE","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/d2c2c0b6-6019-4629-b481-eece9c1d1329/","filing_uuid":"d2c2c0b6-6019-4629-b481-eece9c1d1329","filing_type":"RR","filing_type_display":"Registration","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/d2c2c0b6-6019-4629-b481-eece9c1d1329/print/","filing_document_content_type":"text/html","income":null,"expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Nora M. Wong","dt_posted":"2026-09-04T11:46:45-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"325 Hudson St","registrant_address_2":"4th floor","registrant_different_address":null,"registrant_city":"New York","registrant_state":"NY","registrant_zip":"10013","registrant":{"id":401111004,"url":"https://lda.gov/api/v1/registrants/401111004/","house_registrant_id":null,"name":"CUREPSP","description":null,"address_1":"325 Hudson Street","address_2":"4th Floor","address_3":null,"address_4":null,"city":"New York","state":"NY","state_display":"New York","zip":"10013","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"NORA WONG","contact_telephone":"+1 551-306-5982","dt_updated":"2026-09-04T11:34:50.236473-04:00"},"client":{"id":74863,"url":"https://lda.gov/api/v1/clients/74863/","client_id":74863,"name":"CUREPSP","general_description":"Non profit health organization","client_government_entity":null,"client_self_select":true,"state":"NY","state_display":"New York","country":"US","country_display":"United States of America","ppb_state":"NY","ppb_state_display":"New York","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2026-07-17"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Federal funding for biomedical and neurological disease research, including NIH and related federal research programs; FY 2027 appropriations affecting progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), multiple system atrophy (MSA), and related neurodegenerative diseases; (H.R. 7779) HEALTHY BRAINS Act of 2026, including provisions related to neurological disease research and environmental risk factors; congressional resolution recognizing PSP Awareness Month H.Res.1318 and S.Res.752.","foreign_entity_issues":null,"lobbyists":[{"lobbyist":{"id":155101,"prefix":null,"prefix_display":null,"first_name":"NORA","nickname":null,"middle_name":null,"last_name":"WONG","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":155102,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"BALASALLE","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[]},{"general_issue_code":"ENV","general_issue_code_display":"Environment/Superfund","description":"Federal funding for biomedical and neurological disease research, including NIH and related federal research programs; FY 2027 appropriations affecting progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), multiple system atrophy (MSA), and related neurodegenerative diseases; (H.R. 7779) HEALTHY BRAINS Act of 2026, including provisions related to neurological disease research and environmental risk factors; congressional resolution recognizing PSP Awareness Month H.Res.1318 and S.Res.752.","foreign_entity_issues":null,"lobbyists":[{"lobbyist":{"id":155101,"prefix":null,"prefix_display":null,"first_name":"NORA","nickname":null,"middle_name":null,"last_name":"WONG","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":155102,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"BALASALLE","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[]},{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Federal funding for biomedical and neurological disease research, including NIH and related federal research programs; FY 2027 appropriations affecting progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), multiple system atrophy (MSA), and related neurodegenerative diseases; (H.R. 7779) HEALTHY BRAINS Act of 2026, including provisions related to neurological disease research and environmental risk factors; congressional resolution recognizing PSP Awareness Month H.Res.1318 and S.Res.752.","foreign_entity_issues":null,"lobbyists":[{"lobbyist":{"id":155101,"prefix":null,"prefix_display":null,"first_name":"NORA","nickname":null,"middle_name":null,"last_name":"WONG","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":155102,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"BALASALLE","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}]}